Global Antisense Oligonucleotides (ASO) Drug Market Growth 2022-2028
Antisense oligonucleotide (ASO) drugs are small, synthetic single-stranded nucleic acid polymers that can be used to regulate gene expression through a variety of mechanisms.
The global market for Antisense Oligonucleotides (ASO) Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Antisense Oligonucleotides (ASO) Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Antisense Oligonucleotides (ASO) Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Antisense Oligonucleotides (ASO) Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Antisense Oligonucleotides (ASO) Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Antisense Oligonucleotides (ASO) Drug players cover Ionis, Novartis, Biogen, Akcea and Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Antisense Oligonucleotides (ASO) Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Antisense Oligonucleotides (ASO) Drug market, with both quantitative and qualitative data, to help readers understand how the Antisense Oligonucleotides (ASO) Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Antisense Oligonucleotides (ASO) Drug market and forecasts the market size by Type (Fomivirsen, Spinraza and Tegsedi), by Application (Single Gene Rare Disease, Protein Deposition Disease, Chronic Liver Disease and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Fomivirsen
Spinraza
Tegsedi
Waylivra
Vyondys 53
Segmentation by application
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Ionis
Novartis
Biogen
Akcea
Therapeutics
Sarepta Therapeutics
WAVElife
ProQR
Exicure
Secarna
AstraZeneca
The WhiteOak Group, Inc.
Dicerna
Silence
Arrowhead
Alnylam
Chapter Introduction
Chapter 1: Scope of Antisense Oligonucleotides (ASO) Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Antisense Oligonucleotides (ASO) Drug market size (sales and revenue) and CAGR, Antisense Oligonucleotides (ASO) Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Antisense Oligonucleotides (ASO) Drug sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Antisense Oligonucleotides (ASO) Drug sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Antisense Oligonucleotides (ASO) Drug market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Ionis, Novartis, Biogen, Akcea, Therapeutics, Sarepta Therapeutics, WAVElife, ProQR and Exicure, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antisense Oligonucleotides (ASO) Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Antisense Oligonucleotides (ASO) Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Antisense Oligonucleotides (ASO) Drug by Country/Region, 2017, 2022 & 2028
2.2 Antisense Oligonucleotides (ASO) Drug Segment by Type
2.2.1 Fomivirsen
2.2.2 Spinraza
2.2.3 Tegsedi
2.2.4 Waylivra
2.2.5 Vyondys 53
2.3 Antisense Oligonucleotides (ASO) Drug Sales by Type
2.3.1 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Antisense Oligonucleotides (ASO) Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Antisense Oligonucleotides (ASO) Drug Sale Price by Type (2017-2022)
2.4 Antisense Oligonucleotides (ASO) Drug Segment by Application
2.4.1 Single Gene Rare Disease
2.4.2 Protein Deposition Disease
2.4.3 Chronic Liver Disease
2.4.4 Other
2.5 Antisense Oligonucleotides (ASO) Drug Sales by Application
2.5.1 Global Antisense Oligonucleotides (ASO) Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Antisense Oligonucleotides (ASO) Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Antisense Oligonucleotides (ASO) Drug Sale Price by Application (2017-2022)
3 Global Antisense Oligonucleotides (ASO) Drug by Company
3.1 Global Antisense Oligonucleotides (ASO) Drug Breakdown Data by Company
3.1.1 Global Antisense Oligonucleotides (ASO) Drug Annual Sales by Company (2020-2022)
3.1.2 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Company (2020-2022)
3.2 Global Antisense Oligonucleotides (ASO) Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Antisense Oligonucleotides (ASO) Drug Revenue by Company (2020-2022)
3.2.2 Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Company (2020-2022)
3.3 Global Antisense Oligonucleotides (ASO) Drug Sale Price by Company
3.4 Key Manufacturers Antisense Oligonucleotides (ASO) Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antisense Oligonucleotides (ASO) Drug Product Location Distribution
3.4.2 Players Antisense Oligonucleotides (ASO) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antisense Oligonucleotides (ASO) Drug by Geographic Region
4.1 World Historic Antisense Oligonucleotides (ASO) Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Antisense Oligonucleotides (ASO) Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Antisense Oligonucleotides (ASO) Drug Annual Revenue by Geographic Region
4.2 World Historic Antisense Oligonucleotides (ASO) Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Antisense Oligonucleotides (ASO) Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Antisense Oligonucleotides (ASO) Drug Annual Revenue by Country/Region
4.3 Americas Antisense Oligonucleotides (ASO) Drug Sales Growth
4.4 APAC Antisense Oligonucleotides (ASO) Drug Sales Growth
4.5 Europe Antisense Oligonucleotides (ASO) Drug Sales Growth
4.6 Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Growth
5 Americas
5.1 Americas Antisense Oligonucleotides (ASO) Drug Sales by Country
5.1.1 Americas Antisense Oligonucleotides (ASO) Drug Sales by Country (2017-2022)
5.1.2 Americas Antisense Oligonucleotides (ASO) Drug Revenue by Country (2017-2022)
5.2 Americas Antisense Oligonucleotides (ASO) Drug Sales by Type
5.3 Americas Antisense Oligonucleotides (ASO) Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antisense Oligonucleotides (ASO) Drug Sales by Region
6.1.1 APAC Antisense Oligonucleotides (ASO) Drug Sales by Region (2017-2022)
6.1.2 APAC Antisense Oligonucleotides (ASO) Drug Revenue by Region (2017-2022)
6.2 APAC Antisense Oligonucleotides (ASO) Drug Sales by Type
6.3 APAC Antisense Oligonucleotides (ASO) Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antisense Oligonucleotides (ASO) Drug by Country
7.1.1 Europe Antisense Oligonucleotides (ASO) Drug Sales by Country (2017-2022)
7.1.2 Europe Antisense Oligonucleotides (ASO) Drug Revenue by Country (2017-2022)
7.2 Europe Antisense Oligonucleotides (ASO) Drug Sales by Type
7.3 Europe Antisense Oligonucleotides (ASO) Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antisense Oligonucleotides (ASO) Drug by Country
8.1.1 Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Antisense Oligonucleotides (ASO) Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales by Type
8.3 Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antisense Oligonucleotides (ASO) Drug
10.3 Manufacturing Process Analysis of Antisense Oligonucleotides (ASO) Drug
10.4 Industry Chain Structure of Antisense Oligonucleotides (ASO) Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antisense Oligonucleotides (ASO) Drug Distributors
11.3 Antisense Oligonucleotides (ASO) Drug Customer
12 World Forecast Review for Antisense Oligonucleotides (ASO) Drug by Geographic Region
12.1 Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Region
12.1.1 Global Antisense Oligonucleotides (ASO) Drug Forecast by Region (2023-2028)
12.1.2 Global Antisense Oligonucleotides (ASO) Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antisense Oligonucleotides (ASO) Drug Forecast by Type
12.7 Global Antisense Oligonucleotides (ASO) Drug Forecast by Application
13 Key Players Analysis
13.1 Ionis
13.1.1 Ionis Company Information
13.1.2 Ionis Antisense Oligonucleotides (ASO) Drug Product Offered
13.1.3 Ionis Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Ionis Main Business Overview
13.1.5 Ionis Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Antisense Oligonucleotides (ASO) Drug Product Offered
13.2.3 Novartis Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Biogen
13.3.1 Biogen Company Information
13.3.2 Biogen Antisense Oligonucleotides (ASO) Drug Product Offered
13.3.3 Biogen Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biogen Main Business Overview
13.3.5 Biogen Latest Developments
13.4 Akcea
13.4.1 Akcea Company Information
13.4.2 Akcea Antisense Oligonucleotides (ASO) Drug Product Offered
13.4.3 Akcea Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Akcea Main Business Overview
13.4.5 Akcea Latest Developments
13.5 Therapeutics
13.5.1 Therapeutics Company Information
13.5.2 Therapeutics Antisense Oligonucleotides (ASO) Drug Product Offered
13.5.3 Therapeutics Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Therapeutics Main Business Overview
13.5.5 Therapeutics Latest Developments
13.6 Sarepta Therapeutics
13.6.1 Sarepta Therapeutics Company Information
13.6.2 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Offered
13.6.3 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sarepta Therapeutics Main Business Overview
13.6.5 Sarepta Therapeutics Latest Developments
13.7 WAVElife
13.7.1 WAVElife Company Information
13.7.2 WAVElife Antisense Oligonucleotides (ASO) Drug Product Offered
13.7.3 WAVElife Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 WAVElife Main Business Overview
13.7.5 WAVElife Latest Developments
13.8 ProQR
13.8.1 ProQR Company Information
13.8.2 ProQR Antisense Oligonucleotides (ASO) Drug Product Offered
13.8.3 ProQR Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 ProQR Main Business Overview
13.8.5 ProQR Latest Developments
13.9 Exicure
13.9.1 Exicure Company Information
13.9.2 Exicure Antisense Oligonucleotides (ASO) Drug Product Offered
13.9.3 Exicure Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Exicure Main Business Overview
13.9.5 Exicure Latest Developments
13.10 Secarna
13.10.1 Secarna Company Information
13.10.2 Secarna Antisense Oligonucleotides (ASO) Drug Product Offered
13.10.3 Secarna Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Secarna Main Business Overview
13.10.5 Secarna Latest Developments
13.11 AstraZeneca
13.11.1 AstraZeneca Company Information
13.11.2 AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Offered
13.11.3 AstraZeneca Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 AstraZeneca Main Business Overview
13.11.5 AstraZeneca Latest Developments
13.12 The WhiteOak Group, Inc.
13.12.1 The WhiteOak Group, Inc. Company Information
13.12.2 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Offered
13.12.3 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 The WhiteOak Group, Inc. Main Business Overview
13.12.5 The WhiteOak Group, Inc. Latest Developments
13.13 Dicerna
13.13.1 Dicerna Company Information
13.13.2 Dicerna Antisense Oligonucleotides (ASO) Drug Product Offered
13.13.3 Dicerna Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Dicerna Main Business Overview
13.13.5 Dicerna Latest Developments
13.14 Silence
13.14.1 Silence Company Information
13.14.2 Silence Antisense Oligonucleotides (ASO) Drug Product Offered
13.14.3 Silence Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Silence Main Business Overview
13.14.5 Silence Latest Developments
13.15 Arrowhead
13.15.1 Arrowhead Company Information
13.15.2 Arrowhead Antisense Oligonucleotides (ASO) Drug Product Offered
13.15.3 Arrowhead Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Arrowhead Main Business Overview
13.15.5 Arrowhead Latest Developments
13.16 Alnylam
13.16.1 Alnylam Company Information
13.16.2 Alnylam Antisense Oligonucleotides (ASO) Drug Product Offered
13.16.3 Alnylam Antisense Oligonucleotides (ASO) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Alnylam Main Business Overview
13.16.5 Alnylam Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Antisense Oligonucleotides (ASO) Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Antisense Oligonucleotides (ASO) Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Fomivirsen
Table 4. Major Players of Spinraza
Table 5. Major Players of Tegsedi
Table 6. Major Players of Waylivra
Table 7. Major Players of Vyondys 53
Table 8. Global Antisense Oligonucleotides (ASO) Drug Sales by Type (2017-2022) & (K Units)
Table 9. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2017-2022)
Table 10. Global Antisense Oligonucleotides (ASO) Drug Revenue by Type (2017-2022) & ($ million)
Table 11. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2017-2022)
Table 12. Global Antisense Oligonucleotides (ASO) Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Antisense Oligonucleotides (ASO) Drug Sales by Application (2017-2022) & (K Units)
Table 14. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2017-2022)
Table 15. Global Antisense Oligonucleotides (ASO) Drug Revenue by Application (2017-2022)
Table 16. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2017-2022)
Table 17. Global Antisense Oligonucleotides (ASO) Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Antisense Oligonucleotides (ASO) Drug Sales by Company (2020-2022) & (K Units)
Table 19. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Company (2020-2022)
Table 20. Global Antisense Oligonucleotides (ASO) Drug Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Company (2020-2022)
Table 22. Global Antisense Oligonucleotides (ASO) Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Antisense Oligonucleotides (ASO) Drug Producing Area Distribution and Sales Area
Table 24. Players Antisense Oligonucleotides (ASO) Drug Products Offered
Table 25. Antisense Oligonucleotides (ASO) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Antisense Oligonucleotides (ASO) Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share Geographic Region (2017-2022)
Table 30. Global Antisense Oligonucleotides (ASO) Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Antisense Oligonucleotides (ASO) Drug Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country/Region (2017-2022)
Table 34. Global Antisense Oligonucleotides (ASO) Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Antisense Oligonucleotides (ASO) Drug Sales by Country (2017-2022) & (K Units)
Table 37. Americas Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country (2017-2022)
Table 38. Americas Antisense Oligonucleotides (ASO) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country (2017-2022)
Table 40. Americas Antisense Oligonucleotides (ASO) Drug Sales by Type (2017-2022) & (K Units)
Table 41. Americas Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2017-2022)
Table 42. Americas Antisense Oligonucleotides (ASO) Drug Sales by Application (2017-2022) & (K Units)
Table 43. Americas Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2017-2022)
Table 44. APAC Antisense Oligonucleotides (ASO) Drug Sales by Region (2017-2022) & (K Units)
Table 45. APAC Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2017-2022)
Table 46. APAC Antisense Oligonucleotides (ASO) Drug Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Region (2017-2022)
Table 48. APAC Antisense Oligonucleotides (ASO) Drug Sales by Type (2017-2022) & (K Units)
Table 49. APAC Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2017-2022)
Table 50. APAC Antisense Oligonucleotides (ASO) Drug Sales by Application (2017-2022) & (K Units)
Table 51. APAC Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2017-2022)
Table 52. Europe Antisense Oligonucleotides (ASO) Drug Sales by Country (2017-2022) & (K Units)
Table 53. Europe Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country (2017-2022)
Table 54. Europe Antisense Oligonucleotides (ASO) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country (2017-2022)
Table 56. Europe Antisense Oligonucleotides (ASO) Drug Sales by Type (2017-2022) & (K Units)
Table 57. Europe Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2017-2022)
Table 58. Europe Antisense Oligonucleotides (ASO) Drug Sales by Application (2017-2022) & (K Units)
Table 59. Europe Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Antisense Oligonucleotides (ASO) Drug
Table 69. Key Market Challenges & Risks of Antisense Oligonucleotides (ASO) Drug
Table 70. Key Industry Trends of Antisense Oligonucleotides (ASO) Drug
Table 71. Antisense Oligonucleotides (ASO) Drug Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Antisense Oligonucleotides (ASO) Drug Distributors List
Table 74. Antisense Oligonucleotides (ASO) Drug Customer List
Table 75. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Antisense Oligonucleotides (ASO) Drug Sales Market Forecast by Region
Table 77. Global Antisense Oligonucleotides (ASO) Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Antisense Oligonucleotides (ASO) Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Antisense Oligonucleotides (ASO) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Antisense Oligonucleotides (ASO) Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Antisense Oligonucleotides (ASO) Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Antisense Oligonucleotides (ASO) Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Antisense Oligonucleotides (ASO) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Antisense Oligonucleotides (ASO) Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Antisense Oligonucleotides (ASO) Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share Forecast by Application (2023-2028)
Table 95. Ionis Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Ionis Antisense Oligonucleotides (ASO) Drug Product Offered
Table 97. Ionis Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Ionis Main Business
Table 99. Ionis Latest Developments
Table 100. Novartis Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis Antisense Oligonucleotides (ASO) Drug Product Offered
Table 102. Novartis Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Novartis Main Business
Table 104. Novartis Latest Developments
Table 105. Biogen Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Biogen Antisense Oligonucleotides (ASO) Drug Product Offered
Table 107. Biogen Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Biogen Main Business
Table 109. Biogen Latest Developments
Table 110. Akcea Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Akcea Antisense Oligonucleotides (ASO) Drug Product Offered
Table 112. Akcea Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Akcea Main Business
Table 114. Akcea Latest Developments
Table 115. Therapeutics Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Therapeutics Antisense Oligonucleotides (ASO) Drug Product Offered
Table 117. Therapeutics Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Therapeutics Main Business
Table 119. Therapeutics Latest Developments
Table 120. Sarepta Therapeutics Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Offered
Table 122. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Sarepta Therapeutics Main Business
Table 124. Sarepta Therapeutics Latest Developments
Table 125. WAVElife Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. WAVElife Antisense Oligonucleotides (ASO) Drug Product Offered
Table 127. WAVElife Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. WAVElife Main Business
Table 129. WAVElife Latest Developments
Table 130. ProQR Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. ProQR Antisense Oligonucleotides (ASO) Drug Product Offered
Table 132. ProQR Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. ProQR Main Business
Table 134. ProQR Latest Developments
Table 135. Exicure Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Exicure Antisense Oligonucleotides (ASO) Drug Product Offered
Table 137. Exicure Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Exicure Main Business
Table 139. Exicure Latest Developments
Table 140. Secarna Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 141. Secarna Antisense Oligonucleotides (ASO) Drug Product Offered
Table 142. Secarna Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Secarna Main Business
Table 144. Secarna Latest Developments
Table 145. AstraZeneca Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 146. AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Offered
Table 147. AstraZeneca Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. AstraZeneca Main Business
Table 149. AstraZeneca Latest Developments
Table 150. The WhiteOak Group, Inc. Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 151. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Offered
Table 152. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. The WhiteOak Group, Inc. Main Business
Table 154. The WhiteOak Group, Inc. Latest Developments
Table 155. Dicerna Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 156. Dicerna Antisense Oligonucleotides (ASO) Drug Product Offered
Table 157. Dicerna Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. Dicerna Main Business
Table 159. Dicerna Latest Developments
Table 160. Silence Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 161. Silence Antisense Oligonucleotides (ASO) Drug Product Offered
Table 162. Silence Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 163. Silence Main Business
Table 164. Silence Latest Developments
Table 165. Arrowhead Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 166. Arrowhead Antisense Oligonucleotides (ASO) Drug Product Offered
Table 167. Arrowhead Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 168. Arrowhead Main Business
Table 169. Arrowhead Latest Developments
Table 170. Alnylam Basic Information, Antisense Oligonucleotides (ASO) Drug Manufacturing Base, Sales Area and Its Competitors
Table 171. Alnylam Antisense Oligonucleotides (ASO) Drug Product Offered
Table 172. Alnylam Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 173. Alnylam Main Business
Table 174. Alnylam Latest Developments
List of Figures
Figure 1. Picture of Antisense Oligonucleotides (ASO) Drug
Figure 2. Antisense Oligonucleotides (ASO) Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antisense Oligonucleotides (ASO) Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Antisense Oligonucleotides (ASO) Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Fomivirsen
Figure 10. Product Picture of Spinraza
Figure 11. Product Picture of Tegsedi
Figure 12. Product Picture of Waylivra
Figure 13. Product Picture of Vyondys 53
Figure 14. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type in 2021
Figure 15. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2017-2022)
Figure 16. Antisense Oligonucleotides (ASO) Drug Consumed in Single Gene Rare Disease
Figure 17. Global Antisense Oligonucleotides (ASO) Drug Market: Single Gene Rare Disease (2017-2022) & (K Units)
Figure 18. Antisense Oligonucleotides (ASO) Drug Consumed in Protein Deposition Disease
Figure 19. Global Antisense Oligonucleotides (ASO) Drug Market: Protein Deposition Disease (2017-2022) & (K Units)
Figure 20. Antisense Oligonucleotides (ASO) Drug Consumed in Chronic Liver Disease
Figure 21. Global Antisense Oligonucleotides (ASO) Drug Market: Chronic Liver Disease (2017-2022) & (K Units)
Figure 22. Antisense Oligonucleotides (ASO) Drug Consumed in Other
Figure 23. Global Antisense Oligonucleotides (ASO) Drug Market: Other (2017-2022) & (K Units)
Figure 24. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2017-2022)
Figure 25. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application in 2021
Figure 26. Antisense Oligonucleotides (ASO) Drug Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Company in 2021
Figure 28. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Geographic Region in 2021
Figure 30. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2017-2022)
Figure 31. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country/Region in 2021
Figure 32. Americas Antisense Oligonucleotides (ASO) Drug Sales 2017-2022 (K Units)
Figure 33. Americas Antisense Oligonucleotides (ASO) Drug Revenue 2017-2022 ($ Millions)
Figure 34. APAC Antisense Oligonucleotides (ASO) Drug Sales 2017-2022 (K Units)
Figure 35. APAC Antisense Oligonucleotides (ASO) Drug Revenue 2017-2022 ($ Millions)
Figure 36. Europe Antisense Oligonucleotides (ASO) Drug Sales 2017-2022 (K Units)
Figure 37. Europe Antisense Oligonucleotides (ASO) Drug Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Revenue 2017-2022 ($ Millions)
Figure 40. Americas Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country in 2021
Figure 41. Americas Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country in 2021
Figure 42. United States Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region in 2021
Figure 47. APAC Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Regions in 2021
Figure 48. China Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country in 2021
Figure 55. Europe Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country in 2021
Figure 56. Germany Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country in 2021
Figure 63. Egypt Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Antisense Oligonucleotides (ASO) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Antisense Oligonucleotides (ASO) Drug in 2021
Figure 69. Manufacturing Process Analysis of Antisense Oligonucleotides (ASO) Drug
Figure 70. Industry Chain Structure of Antisense Oligonucleotides (ASO) Drug
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets